FIELD: pharmacology.
SUBSTANCE: invention refers to cancer pemetrexed compositions in an airtight container that contains pemetrexed or its pharmaceutically acceptable salt, as the active ingredient, as well as N-acetyl-L-cysteine and sodium citrate, where this the composition has gaseous oxygen content of 3% vol./vol. in the container free space or less relative to the total amount of free space.
EFFECT: invention implementation allows to obtain a stable pemetrexed composition.
7 cl, 14 tbl, 39 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| STABILIZED PEMETREXED COMPOSITION | 2013 |
|
RU2620341C2 |
| STABLE PHARMACEUTICAL COMPOSITION OF 5,10-METHYLENTETRAHYDROFOLATE | 2004 |
|
RU2343923C2 |
| STABLE FORMULATIONS OF BORTEZOMIB | 2011 |
|
RU2529800C2 |
| COMPOSITIONS OF TETRAHYDROBIOPTERINE AND METHODS OF ITS QUANTITATIVE ASSESSMENT | 2008 |
|
RU2486899C2 |
| STABILIZED PHARMACEUTICAL COMPOSITIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES | 2014 |
|
RU2702345C2 |
| STABLE INJECTABLE COMPOSITION CONTAINING DICLOFENAC AND THIOCOLCHICOSIDE | 2013 |
|
RU2666993C2 |
| DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | 2015 |
|
RU2684105C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING PALANOSETRON AS AN ACTIVE INGREDIENT | 2017 |
|
RU2732407C1 |
| ACETAMINOPHEN COMPOSITION | 2011 |
|
RU2583922C2 |
| STABLE LYOPHILIZATES CONTAINING 5,10-METHYLENE-(6R)-TETRAHYDROFOLIC ACID | 2018 |
|
RU2796570C2 |
